Rare disease pharma company selects Veeva software solutions

The rare disease pharmaceutical company, Santhera Pharmaceuticals, has chosen Veeva CRM and Veeva OpenData as commercial software and data platform for its first product launch.

In a recent survey performed by Veeva, it was found that the majority of respondents believed a top customer data priority is having a complete and real-time view of the customer with less than half being satisfied with their current customer data. The survey summary highlighted that although customer data quality is improving there is still a gap to transverse for the industry to reach its desired level. Additionally, although there is a digital transformation occurring within the life sciences, it was found that customer data still lags behind.

“There is a major transition happening across the industry as companies focus on better customer data for improved commercial effectiveness,” explained Guillaume Roussel, director of strategy for Veeva OpenData. “Veeva OpenData and Veeva CRM are changing how the life sciences industry sources and manages data to drive greater speed, productivity and execution globally.”